Higher prevalence of vitamin D deficiency among arthroplasty patients presenting in winter. [PDF]
Beadel H, Sandiford NA.
europepmc +1 more source
Discovering TEAD4 modulators for hepatocellular carcinoma: a GAN-enabled generative modelling framework. [PDF]
Premnath V +3 more
europepmc +1 more source
Improvements in Serum 25(OH)D Following Stoss Dosing in People With Cystic Fibrosis and Variable Adherence to Maintenance Regimens: A Retrospective Chart Review. [PDF]
Gordon K +4 more
europepmc +1 more source
Vitamin D and Vitamin D Analogues in Hemodialysis Patients: A Review of the Literature. [PDF]
Kantartzi K +6 more
europepmc +1 more source
Hypercalcemia in Patients After Kidney Transplantation. [PDF]
Miedziaszczyk M +8 more
europepmc +1 more source
The Effect of Vitamin D on the Humoral Immune Response of Calves to the Sheeppox Virus Vaccine. [PDF]
Seyed Ali MR +5 more
europepmc +1 more source
Erratum to "Treatment of Hypovitaminosis D With Cholecalciferol in Dogs With Protein-Losing Enteropathies: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial". [PDF]
europepmc +1 more source
Related searches:
The primary source of exposure to cholecalciferol in dogs and cats is ingestion of rodenticide baits with vitamin D3 as the active ingredient. Other sources of this toxin are human medications and rarely, contaminated pet food. Although the reported lethal dose 50% for cholecalciferol is 88 mg/kg, deaths have been seen with an individual exposure of 2 ...
Michael E, Peterson, Kerstin, Fluegeman
openaire +2 more sources
Ergocalciferol and Cholecalciferol in CKD
American Journal of Kidney Diseases, 2012The development of chronic kidney disease (CKD) is accompanied by a progressive decrease in the ability to produce 1,25-dihydroxyvitamin D. Pharmacological replacement with active vitamin D therefore has been a cornerstone of secondary hyperparathyroidism therapy in the end-stage renal disease population treated by long-term dialysis.
Sagar U, Nigwekar +2 more
openaire +2 more sources

